Elgun SAMADOV, Rovshan HASANOV, Nuru BAYRAMOV, Aytekin ÜNLÜ, Patrizio PETRONE

Surgical management of insulinomas at the Azerbaijan Medical University: a retrospective study of 21 cases over a 10-year period

Background/aim: This study represents the first report that evaluates the experience gathered from diagnosis, surgical treatment and outcome of insulinoma patients from Azerbaijan. Materials and methods: We retrospectively review of insulinoma patients for a 10-year period. Collected data included patient demographics, laboratory and imaging tests, detailed surgical reports, histopathological examination of resected specimens, and clinical follow-up. Results: Twenty-one insulinoma patients were identified. Male patients comprised 52.4%; mean age was 44 years. Mean time to diagnosis was 14 months; 61% patients had ≥3 medical referrals due to hypoglycemia-related symptoms. Diagnosis sensitivity of CT, MRI and US was 85%, 80%, and 55%, respectively. The mean glucose, insulin, C-peptide levels were 35.7 ± 9.5 mg/dL, 33.5 ± 21.9 µU/mL, and 3.74 ± 1.88 ng/mL, respectively. Pancreatic head and tail were the most frequent tumor locations; mean tumor size was 1.5 ± 0.7 cm. No statistical association was found between the tumor size and preoperative glucose, C-peptide and insulin levels. Distal pancreatectomy and enucleation were the most common surgical procedures. Local tumor recurrence rate was 14%. There was no mortality. Conclusions: To prevent delayed diagnoses, physicians should be familiar with the typical symptoms of these rare tumors.

PDF

___

1. Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S et al. Diagnosis and management of insulinoma. World Journal of Gastroenterology 2013; 19 (6): 829-837. doi: 10.3748/wjg.v19. i6.829
2. Service FJ, MacMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clinic Proceedings 1991; 66 (7): 711-719. doi: 10.1016/s0025-6196(12)62083-7
3. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C et al. One hundred years after “carcinoid” epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. Journal of Clinical Oncology 2008; 26 (18): 3063-3072. doi: 10.1200/JCO.2007.15.4377
4. Turaga KK, Kvols LK. Recent progress in the understanding, diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors. CA: A Cancer Journal for Clinicians 2011; 61 (2): 113-132. doi: 10.3322/caac.20097
5. Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Archives 1995; 425 (6): 547-560. doi: 10.1007/BF00199342
6. Aggeli C, Nixon AM, Karoumpalis I, Kaltsas G, Zografos GN. Laparoscopic surgery for pancreatic insulinomas: an update. Hormones (Athens) 2016; 15 (2): 157-169. doi: 10.14310/ horm.2002.1670
7. Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP et al. Improved contemporary surgical management of insulinomas: 25-year experience at the Massachusetts General Hospital. Annals of Surgery 2008; 247 (1): 165-172. doi: 10.1097/SLA.0b013e31815792ed
8. O’Shea D, Rohrer-Theurs AW, Lynn JA, Jackson JE, Bloom SR. Localization of insulinomas by selective intraarterial calcium injection. Journal of Clinical Endocrinology and Metabolism 1996; 81 (4): 1623-1627. doi: 10.1210/jcem.81.4.8636378
9. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula:
11 years after. Surgery 2017; 161 (3): 584-591. doi: 10.1016/j. surg.2016.11.014
10. Bozbora A, Barbaros U, Erbil Y, Ozarmagan S, Mercan S. Is laparoscopic enucleation the gold standard in selected cases with insulinoma? Journal of Laparoendoscopic & Advanced Surgical Technique Part A 2004; 14 (4): 230-233. doi: 10.1089/ lap.2004.14.230
11. Besim H, Korkmaz A, Hamamci O, Karaahmetoglu S. Review of eight cases of insulinoma. East African Medical Journal 2002; 79 (2): 368-372. doi: 10.4314/eamj.v79i7.8841
12. Kalafat H, Mihmanli I, Saribeyoglu K, Belli A. Intraoperative Doppler ultrasound: a reliable diagnostic method in insulinoma. Hepatogastroenterology 2007; 54 (76): 1256-1258.
13. Karakoc D, Ozdemir A, Sayek I. Insulinoma: an evaluation by a single institution. Acta Chirurgica Belgica 2008; 108 (5): 569- 573. doi: 10.1080/00015458.2008.11680287
14. Borazan E, Aytekin A, Yilmaz L, Elci M, Karaca MS et al. Multifocal insulinoma in pancreas and effect of intraoperative ultrasonography. Case Reports in Surgery 2015; 2015: 375124. doi: 10.1155/2015/375124
15. Zhao YP, Zhan HX, Zhang TP, Cong L, Dai MH. Surgical management of patients with insulinomas: result of 292 cases in a single institution. Journal of Surgical Oncology 2011; 103 (2): 169-174. doi: 10.1002/jso.21773
16. Wei J, Liu X, Xu W, Gao W, Jiang K. Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution. Langenbeck’s Archives of Surgery 2016; 401 (7): 1019-1025. doi: 10.1007/s00423-016-1496-y
17. Yu J, Ping F, Zhang H, Li W, Yuan T. Clinical management of malignant insulinoma: a single Institution’s experience over three decades. BMC Endocrine Disorders 2018; 18 (1): 92. doi: 10.1186/s12902-018-0321-8
18. Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. Journal of Clinical Endocrinology and Metabolism 2009; 94 (4): 1069- 1073. doi: 10.1210/jc.2008-2031
19. Vaidakis D, Karoubalis J, Pappa T, Piaditis G, Zografos GN. Pancreatic insulinoma: current issues and trends. Hepatobiliary & Pancreatic Diseases International 2010; 9 (3): 234-241.
20. Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clinic Proceedings 1991; 66: 711-719. doi: 10.1016/s0025-6196(12)62083-7
21. Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH. Insulinomas associated with multiple endocrine neoplasia type 1: the need for different surgical approach. Surgery 1991; 110 (6): 998-1004.
22. Bartsch DK, Albers M, Knoop R, Kann PH, Fendrich V et al. Enucleation and limited pancreatic resection provide longterm cure for insulinoma in multiple endocrine neoplasia type 1. Neuroendocrinology 2013; 98 (4): 290-298. doi: 10.1159/000357779
23. de Herder WW, Niederle B, Scoazec JY, Pauwels S, Kloppel G et al. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 2006; 84 (3): 183-188. doi: 10.1159/000098010
24. Crippa S, Zerbi A, Boninsegna L, Capitanio V, Partelli S et al. Surgical management of insulinomas: short- and longterm outcomes after enucleations and pancreatic resections. Archives of Surgery 2012; 147 (3): 261-266. doi: 10.1001/ archsurg.2011.1843
25. Tamm EP, Bhosale P, Lee JH, Rohren EM. State of the art imaging of pancreatic neuroendocrine tumors. Surgical Oncology Clinics of North America 2016; 25 (2): 375-400. doi: 10.1016/j.soc.2015.11.007
26. Druce MR, Muthuppalaniappan VM, O’Leary B, Chew SL, Drake WM et al. Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation. European Journal of Endocrinology 2010; 162 (5): 971-978. doi: 10.1530/EJE-10- 0056